SA

Sundari Anupindi

Active Director Director DIN 03089070
DIN 03089070 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2010
Shareholding value •••• Premium profile

About Sundari Anupindi

Data last updated:

Sundari Anupindi is a Director at Nan Pharma Private Limited (since 2010). The company operates in Pharma. Nan Pharma Private Limited reported revenue of ₹29.5 Lakh (FY 2022).

DIN 03089070
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2010
Oldest Company Age 16 yrs
Largest company Nan Pharma Private Limited · ₹29.5 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nan Pharma Private Limited U24232AP2010PTC069300
Director05 Jul 20102010₹29.5 Lakh (FY 2022)Active

Board colleagues of Sundari Anupindi

Directorship timeline

Open interactive timeline →
Nan Pharma Private Limited
Premium access

Shareholding and investment profile for Sundari Anupindi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sundari Anupindi

Sundari Anupindi currently holds 1 directorship: Nan Pharma Private Limited (Director, since 05 Jul 2010, revenue ₹29.5 Lakh (FY 2022)).

Sundari Anupindi was first appointed on 05 Jul 2010 as Director at Nan Pharma Private Limited.

The current boards of Sundari Anupindi's companies include Appala Narasimha Murthy Nukala (Nan Pharma Private Limited), Surya Venkata Satya Ganti Girija (Nan Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available